Christopher Hackenbruch

Statistics

Publications

Citations

H-Index

Active since

2014

Affiliations

Deutsches Konsortium für Translationale Krebsforschung(Current)

University of Tübingen

University Children's Hospital Tübingen

German Cancer Research Center

Christopher Hackenbruch is an author at Deutsches Konsortium für Translationale Krebsforschung specializing in mucosal immunology, immunoregulation, and mucosal t cells.

Publications per year

2014–2024

Publications

Isolation of T Cells from the Gut

Sonja Reißig, Christopher Hackenbruch, Nadine Hövelmeyer · Methods in molecular biology · 2014 · 34 citations

Life Sciences, Cell Biology, Immunology +12

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Christopher Hackenbruch, Jens Bauer, Jonas S. Heitmann et al. · Frontiers in Oncology · 2024 · 14 citations · Full text

Life Sciences, Immunology, Oncology +17

Updated results on the bispecific PSMAxCD3 antibody CC-1 for treatment of prostate cancer.

Jonas S. Heitmann, Christopher Hackenbruch, Juliane S. Walz et al. · Journal of Clinical Oncology · 2024 · 11 citations

Medicine, Immunology, Oncology +17

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome

Christopher Hackenbruch, Yacine Maringer, Christian M. Tegeler et al. · Viruses · 2023 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–4 of 4